The growing demand for lightweight and high-strength materials in industries like aerospace and automotive is bolstering the titanium market’s growth. One of the drivers of the global titanium market is the aerospace industry. Westford, USA, Dec. 01, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the titanium market size will attain a value of USD 52.8 billion by 2031, with a CAGR of 7.96% over the forecast period (2024-2031). Surging demand for medical implants and the growing use of titanium in automotive and aerospace industries are estimated to bolster titanium market growth in the future. Rapid industrialization and urbanization are also forecasted to create new opportunities for titanium companies in the long run.  Browse in-depth TOC on “Titanium Market”  Pages – 157 Tables – 65 Figures –...

Salicylic acid is used to make haircare and skin care products, and consumers are becoming more aware of its benefits. This is expected to drive demand over the forecast period. Westford, USA, Dec. 01, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global salicylic acid market share will reach a value of USD 886.9 Million by 2031, with a CAGR of 7.5% during the forecast period (2024-2031). The increasing application of salicylic acid in such industries as food preservatives, cosmetics products, and medicines is contributing to the salicylic acid market growth. Salicylic acid is used in acne treatments, shampoos that fight against dandruff, and other skincare products due to its anti-inflammatory, antibacterial, and exfoliating properties. The increasing prevalence of dermatological disorders among adolescents and young adults,...

LONDON, Nov. 29, 2024 (GLOBE NEWSWIRE) — Icona Capital, a leading alternative investment company, has entered into a binding agreement with Cromwell Property Group to acquire their European fund management platform and associated co-investments via Stoneweg, a real estate manager, which totals up to €3.9 billion of real estate assets under management, for a total consideration of €280 million, this includes:100% interest in Cromwell Europe Limited 27.8% unitholding in CEREIT, a real estate investment trust listed in Singapore with a €2.2 billion portfolio 100% interest in the Singapore-based Manager of CEREIT 50% interest in the Cromwell Urban Italy Logistics FundThe enlarged group led by Icona’s founder and current CEO, Max-Hervé George (Stoneweg Strategic Shareholder), Stoneweg’s co-founders, Jaume Sabater (CEO) and Joaquin...

TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) — O2Gold Inc. (NEX: OTGO.H) (“O2Gold” or the “Company”) is pleased to provide an additional update on its pending acquisition of a gold mining exploration property in Quebec through the purchase of all of the issued and outstanding shares of Quebec Aur Ltd. (the “Target”) pursuant to a share exchange agreement entered into by the Company with the Target and its shareholders dated April 15, 2024, as amended November 14, 2024 (the “Acquisition”). Today, the Company received an extension from the TSX Venture Exchange to close its previously announced non-brokered private placement financing of 15 million subscription receipts and 15 million flow-through subscription receipts for aggregate gross proceeds to the Company of $1.5 million (the “Offering”). The Company now has until January 6, 2025,...

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) — Future Vision II Acquisition Corp., (NASDAQ: FVNNU) a publicly traded special purpose acquisition company (the “Future Vision”) and Viwo Technology Inc., a Cayman Islands exempted company operating its business via wholly owned entities in China (“Viwo”), today announced that, on November 28, 2024, they have entered into a definitive merger agreement. A newly created merger subsidiary of Future Vision will be merged with and into Viwo, with Viwo being the surviving entity and becoming a wholly owned subsidiary of Future Vision (the “Business Combination”). Upon closing of the transaction, Future Vision will change its name to “Viwo Inc.” The Business Combination provide for a valuation of Viwo and its subsidiaries and businesses of $100,000,000.00. Valued at $10.05 per share equaling the...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree VOLEX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Aviva PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to the...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”). BANGALORE, India, Nov. 29, 2024 (GLOBE NEWSWIRE) — Statement regarding Spire Healthcare Group plc (“Spire”) In response to recent media speculation, Narayana Health confirms that it does not intend to make an offer for Spire. This is a statement to which Rule 2.8 of the Code applies. Accordingly, Narayana Health (and any person acting in concert with it) is, except in the circumstances set out below or otherwise with the consent of the the Panel on Takeovers and Mergers (the “Panel”), bound by the restrictions...